Results 1 to 10 of about 4,276 (147)

巨噬细胞炎症蛋白-1α在多发性骨髓瘤中的表达 [PDF]

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2007
【目的】探讨巨噬细胞炎症蛋白-1α(MIP-1α)在多发性骨髓瘤中的表达及临床意义。【方法】夹心酶联免疫吸附法(ELISA)定量检测实验组43例患者、15例对照组,以及随访37例治疗3疗程后骨髓血浆MIP-1α的水平。【结果】①65.1%患者MIP-1α水平增高,其中实验组明显高于对照组(t=3.569,P=0〈0.01),实验组中的活动进展期患者明显高于稳定期、正常人及其他血液病患者(P均〈0.05);骨质破坏〉2处患者明显高于骨质破坏≤2处的患者(t=5.56,P=0〈0.01 ...
王晓桃   +5 more
doaj   +2 more sources

Experimental study on sinomenine derivative modulating chemokine receptor in multiple myeloma cells [PDF]

open access: yes, 2023
Background and purpose: The interaction of CXC motif chemokine receptor (CXCR) on the cell surface of multiple myeloma (MM) with chemokines in the bone marrow microenvironment is involved in proliferation, survival and extramedullary invasion of MM cells.
JU Shenaonan, WANG Yingying, TANG Yong, YAO Yiyun, WU Yingli, ZHU Qi
core   +1 more source

双膦酸盐类药物用于肿瘤辅助治疗的临床研究进展 [PDF]

open access: yes, 2018
双膦酸盐是用于骨骼疾病及钙代谢性疾病治疗的一类药物,主要用于治疗骨质疏松症、佩吉特病、高钙血症等。同时临床研究显示双膦酸盐还可用于多发性骨髓瘤、乳腺癌、肾癌、前列腺癌等疾病的辅助治疗,改善患者的临床结局,尤其是唑来膦酸盐的抗肿瘤效果更具优势,被广泛应用于多种恶性肿瘤的临床研究。本文就双膦酸盐在肿瘤辅助治疗中的临床研究进展进行综述。国家自然科学基金面上项目 ...
何斌   +4 more
core   +1 more source

Efficacy and Safety of Carfilzomib in the Treatment of Multiple Myeloma:A Systematic Evaluation [PDF]

open access: yes, 2019
peer reviewed题目: 卡非佐米治疗多发性骨髓瘤的疗效及安全性的系统评价. 目的: 评估卡非佐米(Carfizomib)治疗多发性骨髓瘤(multiple myeloma,MM)的疗效及安全性. 方法: 计算机检索PubMed、EMbase、Cochrane library、MEDLINE数据库关于卡非佐米治疗MM的研究,提取临床特征和结果,使用Stata 12.0软件进行Meta分析.
Luo, Tao, Xia, Hai-Long
core   +1 more source

以腕管综合征为首发症状的多发性骨髓瘤1例

open access: yesZhongguo shiyan zhenduanxue, 2021
多发性骨髓瘤(MM)是一种不可治愈的浆细胞恶性肿瘤,常表现为患者的骨骼损害、贫血、高钙血症、肾脏损害等[1-2]。腕管综合征(CTS)是最常见的周围神经卡压性疾病。多数为特发性,部分可由于腕管内肿物、屈肌腱滑膜炎、月骨掌侧脱位等导致[3],而以腕管综合征为首发症状的多发性骨髓瘤较为少见。本文报道了1例以腕管综合征为首发症状的多发性骨髓瘤病例。
周熊垚, 张展, 崔树森
doaj  

肝、胃等多个少见脏器累及的复发多发性骨髓瘤1例

open access: yesZhongguo shiyan zhenduanxue, 2023
多发性骨髓瘤(MM)是造血系统浆细胞来源的恶性肿瘤,复发时大部分患者仍表现为骨髓恶性浆细胞增高、高钙、肾损害、贫血、骨病等骨髓瘤相关的表现。本文报道1例多发性骨髓瘤髓外复发病例,以肝脏、胃肠道、胰腺及腹腔淋巴结等多个少见部位累及为主,报道如下。1 临床资料患者,男性,58岁,以“腰痛伴乏力5天”于2018年3月首次入院,既往体健。入院查体:贫血貌。病初检查,
官明泽   +4 more
doaj  

Research progress in nursing of multiple myeloma with ostalgia (多发性骨髓瘤骨痛患者护理模式研究进展)

open access: yes中西医结合护理, 2023
This paper summarized the common types of nursing for patients with multiple myeloma with ostalgia, including care bundles, extended care, Traditional Chinese Medicine emotional care, mind-mapping based care, PRECEDE-PROCEED mode-based nursing ...
WANG Qiumei (王秋梅)
doaj   +1 more source

Effect of Continue Nursing on Medication Adherence and Quality of Life of Patients with Multiple myeloma [PDF]

open access: yes
目的 探讨延续护理对多发性骨髓瘤患者生活质量和服药依从性的影响。方法 将73例完成治疗的多发性骨髓瘤患者随机分为观察组(37例)和对照组(36例),出院时均按照常规进行出院指导。观察组出院后给予3个月延续护理。3个月后,比较两组患者的生活质量、服药依从性。结果 在躯体、角色、情绪以及社会功能和总体健康状况5个方面,以及服药依从性的得分,观察组均大于对照组,且差异具有统计学意义(р<0.05)。结论 延续护理可以提高多发性骨髓患者的躯体、角色、情绪以及社会功能和总体健康状况 ...
LI, Ye   +4 more
core   +2 more sources

Participation in Advance Care Planning and Associated Factors among Surrogate Decision Makers of Patients with Hematologic Malignancies [PDF]

open access: yes, 2022
BackgroundAdvance care planning (ACP) helps patients to obtain medical care meeting their values, goals and preferencesunder the circumstances of loss of decision-making ability.
WANG Tianhang, WANG Wen, SHEN Wenting, SHI Baoxin
core   +1 more source

The role of hedgehog pathway and autophagy in the mechanism of acquired chemoresistance in multiple myeloma [PDF]

open access: yes, 2015
在多发性骨髓瘤的临床治疗中,化疗耐药现象仍然是治疗失败的主要原因之一。为了更好地了解多发性骨髓瘤的化疗耐药性及相关的机制,我们建立了阿霉素(doxorubicin,DOX)耐药的细胞系多发性骨髓瘤细胞系RPMI8226/R(doxorubicin-resistantcellline),DOX对8226/R的半数抑制率(IC50)是对DOX敏感的细胞系RPMI8226/S(chemosensitivecellline)的5~6倍。我们发现在多发性骨髓瘤耐药性的诱导过程中存在Hedgehog(Hh ...
黄潇
core  

Home - About - Disclaimer - Privacy